Ardelyx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.About ARDX
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines.
CEOMichael G. Raab
CEOMichael G. Raab
Employees395
Employees395
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2007
Founded2007
Employees395
Employees395
ARDX Key Statistics
Market cap1.44B
Market cap1.44B
Price-Earnings ratio-24.99
Price-Earnings ratio-24.99
Dividend yield—
Dividend yield—
Average volume2.53M
Average volume2.53M
High today$5.95
High today$5.95
Low today$5.73
Low today$5.73
Open price$5.81
Open price$5.81
Volume2.52M
Volume2.52M
52 Week high$6.78
52 Week high$6.78
52 Week low$3.21
52 Week low$3.21
Stock Snapshot
With a market cap of 1.44B, Ardelyx(ARDX) trades at $5.94. The stock has a price-to-earnings ratio of -24.99.
On 2025-12-04, Ardelyx(ARDX) stock moved within a range of $5.73 to $5.95. With shares now at $5.94, the stock is trading +3.6% above its intraday low and -0.2% below the session's peak.
Trading activity shows a volume of 2.52M, compared to an average daily volume of 2.53M.
Over the past 52 weeks, Ardelyx(ARDX) stock has traded between a high of $6.78 and a low of $3.21.
Over the past 52 weeks, Ardelyx(ARDX) stock has traded between a high of $6.78 and a low of $3.21.
Analyst ratings
91%
of 11 ratingsBuy
90.9%
Hold
9.1%
Sell
0%
People also own
Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.